Karma Biotechnologies (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$8,000,000
Company Info
Founders
Andrew Gray
Market
Healthcare & Wellness
Coinvestors
Freeflow,Khosla Ventures,SOSV
Company Description

Biotechnology company that developed Xavine vaccine platform to solve autoimmune diseases. Karma Biotechnologies is solving autoimmunity, allergies, and food sensitivities with our Xavine™ precision immunotherapy platform.